TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an update.
Asker Healthcare Group has acquired Cardio Dépôt, a French distributor specializing in cardiology medical devices and consumables. This acquisition is expected to enhance Asker’s product offerings and digital presence in the cardiology field, positively impacting the group’s EBITA margin and supporting its growth strategy.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK107.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe, providing medical products and solutions. The group focuses on improving patient outcomes, reducing total care costs, and ensuring a sustainable value chain. It operates in 19 countries with over 4,500 employees and generates revenues of SEK 16 billion.
Average Trading Volume: 1,210,150
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK34.59B
For detailed information about ASKER stock, go to TipRanks’ Stock Analysis page.